HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $67,000 | +13.6% | 912 | 0.0% | 0.02% | +18.8% |
| Q2 2022 | $59,000 | +3.5% | 912 | 0.0% | 0.02% | +23.1% |
| Q1 2022 | $57,000 | +18.8% | 912 | 0.0% | 0.01% | +18.2% |
| Q4 2021 | $48,000 | -25.0% | 912 | 0.0% | 0.01% | -31.2% |
| Q3 2021 | $64,000 | +6.7% | 912 | 0.0% | 0.02% | +6.7% |
| Q2 2021 | $60,000 | -40.6% | 912 | 0.0% | 0.02% | -46.4% |
| Q1 2021 | $101,000 | -6.5% | 912 | 0.0% | 0.03% | -15.2% |
| Q4 2020 | $108,000 | +36.7% | 912 | 0.0% | 0.03% | +17.9% |
| Q3 2020 | $79,000 | -2.5% | 912 | 0.0% | 0.03% | -6.7% |
| Q2 2020 | $81,000 | -2.4% | 912 | 0.0% | 0.03% | -23.1% |
| Q1 2020 | $83,000 | -21.0% | 912 | 0.0% | 0.04% | +11.4% |
| Q4 2019 | $105,000 | -7.1% | 912 | 0.0% | 0.04% | -14.6% |
| Q3 2019 | $113,000 | +3.7% | 912 | 0.0% | 0.04% | 0.0% |
| Q2 2019 | $109,000 | – | 912 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |